{"id":"health-notification-of-stimulant-induced-psychosis-regulations-2010","name":"Health (Notification of Stimulant Induced Psychosis) Regulations 2010","slug":"health-notification-of-stimulant-induced-psychosis-regulations-2010","collection":"regulation","jurisdiction":"wa","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":176757,"registerId":"wa-health-notification-of-stimulant-induced-psychosis-regulations-2010-current","compilationNumber":null,"startDate":"2026-04-05","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Health (Notification of Stimulant Induced Psychosis) Regulations 2010","content":"![Crest]()Western Australia\n\nHealth (Miscellaneous Provisions) Act 1911\n\nHealth (Notification of Stimulant Induced Psychosis) Regulations 2010\n\nWestern Australia\n\nHealth (Notification of Stimulant Induced Psychosis) Regulations 2010\n\nContents\n\n1. Citation 1\n\n2. Commencement 1\n\n3. Terms used 1\n\n4. Stimulant induced psychosis a prescribed condition of health 2\n\n5. Notification by psychiatrists of stimulant induced psychosis 2\n\n6. CEO may require information 3\n\n7. Stimulant Induced Psychosis Register 4\n\n8. Offence to disclose information 4\n\nNotes\n\nCompilation table 6\n\nDefined terms\n\n  \n\nWestern Australia\n\nHealth (Miscellaneous Provisions) Act 1911\n\nHealth (Notification of Stimulant Induced Psychosis) Regulations 2010\n\n##### 1. Citation\n\n\t\tThese regulations are the *Health (Notification of Stimulant Induced Psychosis) Regulations 2010*.\n\n##### 2. Commencement\n\nThese regulations come into operation as follows —\n\n(a) regulations 1 and 2 — on the day on which these regulations are published in the *Gazette*;\n\n(b) the rest of the regulations — on the day that is 3 months after that day.\n\n##### 3. Terms used\n\nIn these regulations —\n\napproved means approved by the CEO;\n\nnotified information means the following information —\n\n(a) information contained in a notification given to the CEO under regulation 5;\n\n(b) information provided to the CEO under regulation 6;\n\npsychiatrist has the meaning given in the *Mental Health Act 2014* section 4;\n\nregister means the Stimulant Induced Psychosis Register referred to in regulation 7(1);\n\nstimulant means —\n\n(a) amphetamine; or\n\n(b) cocaine; or\n\n(c) dexamphetamine; or\n\n(d) methylphenidate; or\n\n(e) methylamphetamine; or\n\n(f) any of the salts of a substance referred to in paragraphs (a) to (e); or\n\n(g) any preparation or admixture containing a substance referred to in paragraphs (a) to (f);\n\nstimulant induced psychosis means a psychotic episode caused by the use of a stimulant, whether or not the person experiencing the psychosis has a pre‑existing psychotic disorder.\n\n[Regulation 3 amended: Gazette 29 Dec 2015 p. 5172; 17 Jan 2017 p. 409‑10; SL 2024/265 r. 31.]\n\n##### 4. Stimulant induced psychosis a prescribed condition of health\n\nStimulant induced psychosis is prescribed as a condition of health to which Part IXA of the Act applies.\n\n##### 5. Notification by psychiatrists of stimulant induced psychosis\n\n(1) A psychiatrist who makes a diagnosis of stimulant induced psychosis in respect of a patient must notify the CEO within 72 hours of making the diagnosis.\n\nPenalty: a fine of not more than $1 000 and not less than —\n\n(a) for a first offence, $100;\n\n(b) for a second offence, $200;\n\n(c) for a third or subsequent offence, $500.\n\n(2) The notice must be in an approved form and must include the following information —\n\n(a) the full name and address of the patient;\n\n(b) the sex and date of birth of the patient;\n\n(c) full details of the diagnosis including details of the stimulant involved (if known);\n\n(d) the full name, address and telephone number of the psychiatrist giving the notification.\n\n##### 6. CEO may require information\n\n(1) If the CEO —\n\n(a) is notified of a diagnosis of stimulant induced psychosis under regulation 5; and\n\n(b) believes, on reasonable grounds, that a person has information that the CEO considers would assist in achieving the objects of Part IXA of the Act with respect to the diagnosis,\n\nthe CEO may, in writing, request the person to provide the information.\n\n(2) A person who receives a request under subregulation (1) must comply with the request within 72 hours after receiving it.\n\nPenalty: a fine of not more than $1 000 and not less than —\n\n(a) for a first offence, $100;\n\n(b) for a second offence, $200;\n\n(c) for a third or subsequent offence, $500.\n\n(3) It is a defence to a prosecution for an offence under subregulation (2) if the person charged proves that the person did not have at the relevant time the information requested.\n\n##### 7. Stimulant Induced Psychosis Register\n\n(1) The CEO is to keep a register to be known as the Stimulant Induced Psychosis Register.\n\n(2) The register is to contain all notified information in respect of each patient who has been prescribed or supplied a stimulant under the *Medicines and Poisons Regulations 2016* regulation 126 in the previous 6 months.\n\n(3) The register is to be kept in the manner and form determined by the CEO.\n\n[Regulation 7 amended: Gazette 17 Jan 2017 p. 410; SL 2024/265 r. 32.]\n\n##### 8. Offence to disclose information\n\nA person who, in the course of the person’s duty, has access to any notified information from which the identity of the person to whom the information relates is apparent or can reasonably be ascertained must not disclose that information unless the disclosure —\n\n(a) is made with the written consent of the person to whom the information relates; or\n\n(b) is to a medical practitioner or authorised health professional who —\n\n(i) is authorised under the *Medicines and Poisons Regulations 2016* regulation 126 to prescribe or supply a stimulant for the treatment of the person to whom the information relates; and\n\n(ii) has prescribed or supplied the stimulant to the person.\n\nPenalty: a fine of not more than $1 000 and not less than —\n\n(a) for a first offence, $100;\n\n(b) for a second offence, $200;\n\n(c) for a third or subsequent offence, $500.\n\n[Regulation 8 amended: Gazette 17 Jan 2017 p. 410; SL 2024/265 r. 33.]\n\n![dline]()\n\nNotes\n\nThis is a compilation of the *Health (Notification of Stimulant Induced Psychosis) Regulations 2010* and includes amendments made by other written laws. For provisions that have come into operation, and for information about any reprints, see the compilation table.\n\nCompilation table\n\n| **Citation** | **Published** | **Commencement** |\n| --- | --- | --- |\n| *Health (Notification of Stimulant Induced Psychosis) Regulations 2010* | 7 Jan 2011 p. 46‑9 | r. 1 and 2: 7 Jan 2011 (see r. 2(a));   Regulations other than r. 1 and 2: 7 Apr 2011 (see r. 2(b)) |\n| *Health (Notification of Stimulant Induced Psychosis) Amendment Regulations 2015* | 29 Dec 2015 p. 5172 | r. 1 and 2: 29 Dec 2015 (see r. 2(a));   Regulations other than r. 1 and 2: 30 Dec 2015 (see r. 2(b)) |\n| *Health Regulations Amendment (Poisons) Regulations 2016* Pt. 2 | 17 Jan 2017 p. 409‑11 | 30 Jan 2017 (see r. 2(b) and *Gazette* 17 Jan 2017 p. 403) |\n| **Reprint 1: The *Health (Notification of Stimulant Induced Psychosis) Regulations 2010* as at 29 Mar 2018** (includes amendments listed above) | | |\n| *Health Regulations Amendment (Medicines and Poisons) Regulations 2024* Pt. 3 | SL 2024/265 11 Dec 2024 | 12 Dec 2024 (see r. 2(c)) |\n\n\nDefined terms\n\n*[This is a list of terms defined and the provisions where they are defined. The list is not part of the law.]*\n\n**Defined term Provision(s)**\n\napproved 3\n\nnotified information 3\n\npsychiatrist 3\n\nregister 3\n\nstimulant 3\n\nstimulant induced psychosis 3\n\n© State of Western Australia 2024.\n\nThis work is licensed under a Creative Commons Attribution 4.0 International Licence (CC BY 4.0). To view relevant information and for a link to a copy of the licence, visit www.legislation.wa.gov.au.\n\nAttribute work as: © State of Western Australia 2024.\n\nBy Authority: GEOFF O. LAWN, Government Printer\n","sortOrder":0}],"analysis":{"issue_detection":{"absurdities":[],"contradictions":[]},"flash_summary":{"complexity_score":4,"scope_assessment":{"changed":true,"description":"The instrument has been amended since inception (see amendment notes and compilation table). Regulations 3, 7 and 8 were amended, updating defined terms and cross‑references (eg, psychiatrist definition), specifying the register’s contents (patients prescribed or supplied a stimulant under Medicines and Poisons Regulations reg 126 in the previous 6 months) and modifying disclosure rules. These later amendments therefore altered the operational scope and data‑capture criteria from the original text."},"complexity_factors":["Cross‑references to other statutes and instruments (Part IXA of the Health (Miscellaneous Provisions) Act 1911; Mental Health Act 2014 definition of psychiatrist; Medicines and Poisons Regulations 2016 reg 126)","Multiple prescribed timeframes (72‑hour reporting and 72‑hour compliance with CEO requests)","Administrative discretion granted to the CEO to request information and to determine register form/manner","Tiered pecuniary penalties for repeated offences and separate offence provisions for disclosure","Register scope tied to recent stimulant prescribing/supply (6‑month lookback) creating interaction with medicines regulatory regimes","Definitions that extend to salts, preparations and admixtures of listed stimulants (broad substance coverage)","Limited authorised disclosure exceptions with specific criteria for prescribers/suppliers","Defence available where requested information is not held (evidential burden on respondent)"],"plain_english_summary":"These regulations make “stimulant induced psychosis” a notifiable condition in Western Australia. Psychiatrists must notify the Chief Executive Officer (CEO) within 72 hours, the CEO may request further information, and a central Stimulant Induced Psychosis Register is kept; limited disclosure rules and penalties for non‑compliance apply.\n\nIt affects psychiatrists, patients experiencing stimulant‑related psychosis and clinicians who prescribe stimulants, because it imposes reporting duties and information‑sharing controls and requires the health CEO to collect and manage identifiable case data."},"flash_summary_failed":{"failed":true,"reason":"A positive credit balance is required for all requests, including BYOK, so fallback providers remain available. Add credits at https://vercel.com/d?to=%2F%5Bteam%5D%2F%7E%2Fai%3Fmodal%3Dtop-up to continue.","source":"analysis-cron"},"summary":{"complexity_score":2,"scope_assessment":{"changed":false,"description":"Scope cannot be meaningfully assessed as the legislative text is unavailable. No comparison between original intent and final form is possible. The title suggests a focused, single-purpose regulatory instrument, but this cannot be verified."},"complexity_factors":["Legislation text is entirely unavailable — analysis is based solely on the title","Regulations (as opposed to Acts) are typically shorter and more focused documents, suggesting lower inherent complexity","The title suggests a narrow, single-purpose notification scheme, which tends to be straightforward in structure","Cannot assess complexity of definitions, exemptions, penalties, or procedural requirements without the actual text"],"plain_english_summary":"Likely requiring health professionals and hospitals to notify government authorities when they treat cases of stimulant‑induced psychosis, this WA regulation would enable public‑health monitoring of harms from stimulants (e.g., methamphetamine, cocaine, MDMA). It mainly affects clinicians and public‑health agencies and matters because it supports tracking, resource allocation, and policy responses to drug‑related mental health crises."},"kimi_summary":{"content_quality":"ok","complexity_score":3,"scope_assessment":{"changed":false,"description":"The regulations remain tightly focused on their original purpose: establishing a notification and register system for stimulant-induced psychosis. The 2024 amendment updated a cross-reference from 'Poisons Regulations 1965' to 'Medicines and Poisons Regulations 2016' — a housekeeping change that does not expand the scope. The scheme has not grown beyond its initial surveillance and public health monitoring intent."},"complexity_factors":["Only 8 substantive regulations with straightforward sequential structure","7 defined terms in a single interpretation section (regulation 3)","Minimal cross-referencing — primarily references to the parent Act (Part IXA) and the Mental Health Act 2014 for the definition of 'psychiatrist'","Simple conditional logic: mandatory notification triggered by single event (diagnosis), with standardised penalty tiers (first/second/subsequent offences)","Single defence provision (regulation 6(3)) regarding unavailable information","No nested exceptions or complex deeming provisions","Recent amendments (2015, 2017, 2024) are minor technical updates updating references to other regulations rather than substantive changes to the scheme"],"plain_english_summary":"These regulations create a mandatory reporting system for psychiatrists in Western Australia when they diagnose a patient with **stimulant-induced psychosis** — a severe mental health episode triggered by drugs like methamphetamine, cocaine, or prescription stimulants such as dexamphetamine and methylphenidate (Ritalin).\n\n**What psychiatrists must do:**\n- **Report within 72 hours** of diagnosing stimulant-induced psychosis\n- Use an approved form with patient details (name, address, date of birth, sex), diagnosis details, and the psychiatrist's contact information\n- **Penalties apply** for failing to report: fines ranging from $100 to $1,000 depending on whether it's a first, second, or repeat offence\n\n**What happens to the information:**\n- The Chief Executive Officer (CEO) of the WA Health Department maintains a **Stimulant Induced Psychosis Register**\n- This register specifically tracks patients who were prescribed stimulants in the previous 6 months under the Medicines and Poisons Regulations\n- The CEO can demand additional information from anyone who might have relevant details, with similar penalties for non-compliance\n\n**Privacy protections:**\n- **Strict confidentiality rules** apply — it's an offence to disclose identifying information from the register\n- Exceptions exist only for: (1) patient consent, or (2) disclosure to the specific medical practitioner who prescribed the stimulant to that patient\n- Breaching confidentiality carries the same fine structure as failing to report\n\n**Why this matters:**\nThis is a **public health surveillance tool** designed to monitor the harms associated with stimulant use — both illicit drugs like methamphetamine and prescription medications. It allows health authorities to track patterns of stimulant-related psychosis and potentially intervene with patients who are receiving prescriptions for stimulant medications. The system balances the need for data collection against privacy concerns by restricting access to the information."}},"importantCases":[],"_links":{"self":"/api/acts/health-notification-of-stimulant-induced-psychosis-regulations-2010","history":"/api/acts/health-notification-of-stimulant-induced-psychosis-regulations-2010/history","analysis":"/api/acts/health-notification-of-stimulant-induced-psychosis-regulations-2010/analysis","conflicts":"/api/acts/health-notification-of-stimulant-induced-psychosis-regulations-2010/conflicts","importantCases":"/api/acts/health-notification-of-stimulant-induced-psychosis-regulations-2010/important-cases","documents":"/api/acts/health-notification-of-stimulant-induced-psychosis-regulations-2010/documents"}}